Small molecule TSC01682 inhibits osteosarcoma cell growth by specifically disrupting the CUL4B-DDB1 interaction and decreasing the ubiquitination of CRL4B E3 ligase substrates.

Bin Chen, Yu Feng, Meimei Zhang, Guangqi Cheng, Hantao Wang

PubMed · 2019 · 11 citations · 18 references

Concepts

Abstract

tumor growth. Collectively, our results suggest that TSC01682 is a potent compound capable of disrupting the CUL4B-DDB1 interaction, and it may be developed as a chemotherapeutic drug for osteosarcoma treatment.

References

18